Prognostic factors for Vogt-Koyanagi-Harada disease

Journal of the Chinese Medical Association

Volumn 66, Issue 3, 2003, Pages 148-154

  Sheu, Shwu Jiuan ^a,b   Kou, Hsi Kung ^c   Chen, Jane Fang ^b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Complications; Prognosis; Recurrence; Vogt Koyanagi Harada disease

Indexed keywords

CORTICOSTEROID; CYTOTOXIC AGENT; METHYLPREDNISOLONE; STEROID;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CATARACT; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE CLASSIFICATION; DRUG MEGADOSE; FEMALE; GLAUCOMA; HLA TYPING; HUMAN; MALE; MEDICAL RECORD; OUTCOMES RESEARCH; PREDICTION; PROGNOSIS; RECURRENT DISEASE; RETINA DETACHMENT; RETROSPECTIVE STUDY; REVIEW; SEX DIFFERENCE; STATISTICAL ANALYSIS; SUBRETINAL NEOVASCULARIZATION; SYSTEMIC DISEASE; TREATMENT PLANNING; VISUAL ACUITY; VOGT KOYANAGI SYNDROME; ARTICLE; MENINGOENCEPHALITIS; MIDDLE AGED; VISION;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; UVEOMENINGOENCEPHALITIC SYNDROME; VISION;

EID: 0037526418     PISSN: 17264901     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Snyder DA, Tessler HA. Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 1980;90:69-75.
2. Moorthy RS, Inomata H, Rao NA. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol 1995;39:265-92.
3. Rao NA. Mechanisms of inflammatory response in sympathetic ophthalmia and VKH syndrome. Eye 1997;11:213-6.
4. Ohno S. Immunological aspects of Behect's disease and Vogt-Koyanagi-Harada disease. Trans Ophthalmol Soc UK 1981;101:335-41.
5. Tagawa Y. Lymphocyte-mediated cytotoxicity against melanocytes antigens in Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol 1978;22:36-41.
6. Gocho K, Kondo I, Yamaki K. Identification of autoreactive T-cells in Vogt-Koyanagi-Harada disease. Invest Ophthalmo Vis Sci 2001;42:2004-9.
7. Numaga J, Matsuki K, Tokunaga K, Juji T, Mochizuki M. Analysis of human leukocyte antigen HLA-DR beta amino acid sequence in Vogt-Koyanagi-Harada syndrome. Invest Ophthalmol Vis Sci 1991;32:1958-61.
8. Shindo Y, Ohno S, Yamamoto T, Nakamura S, Inoko H. Complete association of the HLA-DRB1 *04 and DQB1 *04 alleles with Vogt-Koyanagi-Harada's disease. Hum Immunol 1994; 39:169-76.
9. Islam SM, Numaga J, Fujino Y, Hirata R, Matsuki K, Maeda H, Masuda K. HLA class II genes in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci 1994;35:3890-6.
10. Kim MH, Seong MC, Kwak NH, Yoo JS, Huh W, Kim TG, Han H. Association of HLA with Vogt-Koyanagi-Harada syndrome in Koreans. Am J Ophthalmol 2000;129:173-7.
11. Xiao T, Jiang Y, You X. The association of HLA-DR4 gene subtypes with Vogt-Koyanagi-Harada syndrome. Chin J Ophthalmol 1997;33:268-71.
12. Ohno S, Char DH, Kimura SJ, O'Connor GR. Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 1977;83:735-40.
13. Nussenblatt RB. Clinical studies of Vogt-Koyanagi-Harada's disease at the National Eye Institute, NIH, USA. Jpn J Ophthalmol 1998;32:330-3.
14. Beniz J, Forster DJ, Lean JS, Smith RE, Rao NA. Variations in clinical features of the Vogt-Koyanagi-Harada syndrome. Retina 1991;11:275-80.
15. Chung YM, Yeh TS. Clinical studies on Vogt-Koyanagi-Harada's disease. Acta Soc Ophthalmol Sini 1989;28:842-8.
16. Chou LC, Sheu SJ, Hong MC, WU TT, Chuang CT. Retrospective study of endogenous uveitis at the Kaohsiung Veterans General Hospital. Acta Soc Ophthalmol Sini 2001; 40:371.
17. Chen CH, Kou HK, Kao ML. Ten-year study of Vogt-Koyanagi-Harada disease. Acta Soc Ophthalmol Sini 2001; 40:439.
18. Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an International Committee on Nomenclature. Am J Ophthalmol 2001;131:647-52.
19. Sasamoto Y, Ohno S, Matsuda H. Studies on corticosteroid therapy in Vogt-Koyanagi-Harada disease. Ophthalmologica 1990;201:162-7.
20. Murthy SI, Labree L, Rao NA. New diagnostic criteria of Vogt-Koyanagi-Harada disease (VKH) and its prognostic significance. 2nd International Workshop on Vogt-Koyanagi-Harada Disease, 2001, Tokyo, Japan.
21. Forster DJ, Rao NA, Hill RA, Nguyen QH, Baerveldt G. Incidence and management of glaucoma in Vogt-Koyanagi-Harada syndrome. Ophthalmology 1993;100:613-8.
22. Minnakawa R, Ohno S, Hirose S. Clinical manifestations of Vogt-Koyanagi-Harada disease. Jpn J Clin Ophthalmol 1985; 39:1249-53.
23. Rubsamen PE, Gass JDM. Vogt-Koyanagi-Harada syndrome: clinical course, therapy, and long-term visual outcome. Arch Ophthalmol 1991;109:682-7.
24. Ohno S, Minakawa R, Matsuda H. Clinical studies of Vogt-Koyanagi-Harada's disease. Jpn J Ophthalmol 1988;32: 334-43.
25. Tabbara KF, Chavis PS, Freeman WR. Vogt-Koyanagi-Harada syndrome in children compared to adults. Acta Ophthalmol Scand 1998;76:723-6.
26. Rathinam SR, Vijayalakshmi P, Namperumalsamy P, Nozik RA, Cunningham ET Jr. Vogt-Koyanagi-Harada syndrome in children. Ocul Immunol Inflamm 1998;6:155-61.
27. Read RW, Rechodouni A, Butani N, Johnston R, LaBree LD, Smith RE, Rao NA. Complications and prognostic factors in Vogt-Koyanagi-Harada disease. Am J Ophthalmol 2001; 131:599-606.